Published in Health and Medicine Week, March 13th, 2006
"The combined expertise of these talented new members will allow us to enhance our competitive strengths, customer service and market-leading activities, and represents a significant investment in the future of our company," said Cardiac Science CEO John Hinson. "Their contributions will be essential in driving Cardiac Science toward further growth and success."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.